Bioorganic Chemistry最新文献

筛选
英文 中文
Anti-osteoclastogenic statins from the deep-sea-derived fungus Penicillium commune. 从深海衍生真菌青霉菌中提取的抗破骨细胞他汀类药物。
IF 5.1 2区 医学
Bioorganic Chemistry Pub Date : 2026-11-07 DOI: 10.1016/j.bioorg.2026.110745
Hao-Yu Yu, Yan-Qing Guo, Zheng-Biao Zou, Da-Li Meng, Xian-Wen Yang, Chun-Lan Xie
{"title":"Anti-osteoclastogenic statins from the deep-sea-derived fungus Penicillium commune.","authors":"Hao-Yu Yu, Yan-Qing Guo, Zheng-Biao Zou, Da-Li Meng, Xian-Wen Yang, Chun-Lan Xie","doi":"10.1016/j.bioorg.2026.110745","DOIUrl":"https://doi.org/10.1016/j.bioorg.2026.110745","url":null,"abstract":"<p><p>Three new 11,15-seco-15-O-methyl statins (1-3) were isolated from the deep-sea-derived fungus Penicillium commune MCCC 3A00122, along with 28 known compounds. Their structures were established through comprehensive spectroscopic analyses, including NMR, HRESIMS, OR, and ECD. Compounds 2 and 11 exhibited potent inhibitory activity against RANKL-induced osteoclastogenesis in bone marrow-derived macrophages (BMMs) at concentrations of 0.25-1.0 μM. Furthermore, compound 2 markedly disrupted F-actin ring formation and downregulated the mRNA expression of osteoclast-specific marker genes. RNA sequencing identified 308 differentially expressed genes following compound 2 treatment, including 207 upregulated and 101 downregulated genes. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses linked these transcriptional changes to osteoclast differentiation, bone resorption, inflammatory responses, and cytokine signaling. Protein-protein interaction analysis and molecular docking further nominated osteoclast-associated receptor (OSCAR) as a candidate target. Collectively, these findings identify compound 2 as a promising anti-osteoclastogenic candidate and provide a basis for further mechanistic and in vivo investigations.</p>","PeriodicalId":257,"journal":{"name":"Bioorganic Chemistry","volume":"185 ","pages":"110745"},"PeriodicalIF":5.1,"publicationDate":"2026-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149384904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Asiatic acid as a bioactive pentacyclic triterpenoid scaffold: synthetic derivatization, structure-activity relationships, biological targets, and developability. 作为生物活性五环三萜支架的亚洲酸:合成衍生化、构效关系、生物靶点和可开发性。
IF 5.1 2区 医学
Bioorganic Chemistry Pub Date : 2026-11-06 DOI: 10.1016/j.bioorg.2026.110738
Chi Zhang, Xiazhu Zhang, Qianqian Huang, Jing Sun, Xiaofei Zhang, Dongyan Guo, Fei Luan, Junbo Zou, Yajun Shi
{"title":"Asiatic acid as a bioactive pentacyclic triterpenoid scaffold: synthetic derivatization, structure-activity relationships, biological targets, and developability.","authors":"Chi Zhang, Xiazhu Zhang, Qianqian Huang, Jing Sun, Xiaofei Zhang, Dongyan Guo, Fei Luan, Junbo Zou, Yajun Shi","doi":"10.1016/j.bioorg.2026.110738","DOIUrl":"https://doi.org/10.1016/j.bioorg.2026.110738","url":null,"abstract":"<p><p>Asiatic acid (AA) is an ursane-type pentacyclic triterpenoid from Centella asiatica with anticancer, anti-inflammatory, and neuroprotective activities reported in preclinical models. Its hydroxyl groups, polycyclic framework, and C-28 carboxyl group provide multiple sites for chemical modification, making it a useful scaffold for exploring relationships between molecular structure, biological activity, and developability. This review integrates synthetic derivatization, microbial transformation, structure-activity relationships, molecular mechanisms, delivery strategies, pharmacokinetics, and safety. C-28 esterification and amidation, A-ring oxidation and skeletal modification, C-23 functionalization, and pharmacophore conjugation have generated derivatives with altered activity and selectivity. Improvements reported in selected series depend on the substitution pattern, experimental model, and comparator, limiting generalization across studies. Mechanistic support also varies: some studies provide biochemical inhibition or experimental target engagement, whereas many proposed mechanisms remain supported mainly by cellular pathway responses or computational predictions. Evidence obtained with isolated AA is therefore distinguished from findings involving its derivatives, related triterpenoids, plant extracts, and multicomponent formulations. Lipid and polymeric carriers, hydrogels, microneedles, and inclusion complexes have improved formulation performance or exposure in selected preclinical settings, although the contribution of AA must be separated from carrier effects and other active ingredients. Poor aqueous solubility, low oral bioavailability reported in rats, heterogeneous study conditions, incomplete target validation, and insufficient data connecting exposure, efficacy, and toxicity remain development challenges. The review identifies priorities for AA optimization through matched structural comparisons, mechanistic validation, pharmacokinetic assessment, and safety evaluation, with candidate selection guided by reproducible pharmacological activity, achievable tissue exposure, and an acceptable therapeutic window.</p>","PeriodicalId":257,"journal":{"name":"Bioorganic Chemistry","volume":"185 ","pages":"110738"},"PeriodicalIF":5.1,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149376597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Isoeugenol-derived polyphenolic compounds modulate FOLFOX response, drug resistance, migration, and stemness-associated signatures in HT29 colon cancer cells and an HT29-CSC-enriched population. 异丁香酚衍生的多酚类化合物在HT29结肠癌细胞和HT29- csc富集人群中调节FOLFOX反应、耐药、迁移和干细胞相关特征。
IF 5.1 2区 医学
Bioorganic Chemistry Pub Date : 2026-11-06 DOI: 10.1016/j.bioorg.2026.110714
Sema Bilgin, Yahya Tayhan, Şeyma Yaşar, Seçil Erden Tayhan, Aslı Yıldırım Kocaman, Esra Koç
{"title":"Isoeugenol-derived polyphenolic compounds modulate FOLFOX response, drug resistance, migration, and stemness-associated signatures in HT29 colon cancer cells and an HT29-CSC-enriched population.","authors":"Sema Bilgin, Yahya Tayhan, Şeyma Yaşar, Seçil Erden Tayhan, Aslı Yıldırım Kocaman, Esra Koç","doi":"10.1016/j.bioorg.2026.110714","DOIUrl":"https://doi.org/10.1016/j.bioorg.2026.110714","url":null,"abstract":"<p><p>Chemoresistance, cancer stem cell-associated plasticity, and migratory capacity limit the efficacy of FOLFOX-based chemotherapy in colon cancer. This study investigated the effects of two original isoeugenol-derived polyphenolic compounds, 1 and 2, alone and in combination with FOLFOX, in HT29 colon cancer cells and an HT29-derived cancer stem cell-enriched population. Cell viability was assessed by MTT assay, drug interactions were evaluated using the Chou-Talalay combination index method, wound closure was analyzed by scratch assay, and multidrug resistance-, stemness-, and migration/metastasis-associated gene expression profiles were examined by real-time quantitative polymerase chain reaction. Molecular docking was performed against selected proteins related to drug transport, extracellular matrix remodeling, angiogenesis, and cancer stem cell biology. In HT29 cells, the half-maximal inhibitory concentration (IC₅₀) of FOLFOX decreased from 191.80 μM at 24 h to 15.52 μM at 48 h, while FOLFOX +1 and FOLFOX +2 further reduced the 48-h IC₅₀ values to 13.30 and 14.95 μM, respectively. In the HT29-CSC-enriched population, FOLFOX showed a 48-h IC₅₀ of 26.80 μM, whereas FOLFOX +2 produced the lowest IC₅₀ value among all groups (17.97 μM). Both combinations showed synergistic interactions in cell viability response particularly at moderate effect levels. FOLFOX +2 consistently reduced wound closure in both cellular models. Gene expression analyses revealed target- and cell model-dependent modulation of drug transporter-, stemness-, and migration/metastasis-associated genes rather than uniform suppression. Docking analyses supported the predicted interaction potential of compounds 1 and 2 with multiple cancer-related targets. Overall, these findings suggest that isoeugenol-derived polyphenolic compounds may modulate FOLFOX-associated responses through cell viability-related, migration-related, multidrug resistance-associated, and stemness-linked mechanisms.</p>","PeriodicalId":257,"journal":{"name":"Bioorganic Chemistry","volume":"185 ","pages":"110714"},"PeriodicalIF":5.1,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149376600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Glucocorticoid-based immunology antibody-drug conjugates: linker, warhead, and targeting strategies for anti-inflammatory drug development. 基于糖皮质激素的免疫抗体-药物偶联物:消炎药开发的连接物、弹头和靶向策略。
IF 5.1 2区 医学
Bioorganic Chemistry Pub Date : 2026-11-06 DOI: 10.1016/j.bioorg.2026.110737
Bomi Kang, Jieon Park, Sumin Baek, Heonjoo Jeon, Yumi Heo, Sojeong Hong, Jinha Yu
{"title":"Glucocorticoid-based immunology antibody-drug conjugates: linker, warhead, and targeting strategies for anti-inflammatory drug development.","authors":"Bomi Kang, Jieon Park, Sumin Baek, Heonjoo Jeon, Yumi Heo, Sojeong Hong, Jinha Yu","doi":"10.1016/j.bioorg.2026.110737","DOIUrl":"https://doi.org/10.1016/j.bioorg.2026.110737","url":null,"abstract":"<p><p>Glucocorticoids (GCs) are effective anti-inflammatory agents, but systemic glucocorticoid receptor (GR) activation limits prolonged treatment. Immunology antibody-drug conjugates (iADCs) seek to concentrate GR agonist activity in selected cell populations while limiting systemic payload exposure. This review examines GC- and glucocorticoid receptor modulator (GRM)-based iADCs from a medicinal chemistry perspective, emphasizing the evolution of steroidal payloads and their integration with linker chemistry and antibody targeting. Dexamethasone-, budesonide-, and fluticasone propionate-derived conjugates illustrate how payload potency, hydrophobicity, metabolic stability, and available attachment sites shape linker selection and release strategies. Engineered GRM payloads introduce amine handles, phosphate prodrugs, or metabolically labile groups to address specific constraints in conjugation, solubility, formulation, or systemic exposure. We compare reported phosphate, pyrophosphate, peptide, and self-immolative linker systems, distinguishing proposed release mechanisms from those supported by experimental evidence. We also consider how target expression, antibody internalization, conjugation chemistry, and drug-to-antibody ratio influence delivery and developability. The progression from ABBV-3373 to ABBV-154 highlights the importance of controlling aggregation and conjugate stability for subcutaneous administration. Their clinical development, including the discontinuation of ABBV-154, underscores the need to establish differentiated benefit-risk profiles in patients. Emerging programs further motivate coordinated optimization of payload pharmacology, linker behavior, formulation, and translational biomarkers. GC/GRM-based iADCs remain investigational, and improved targeting or molecular properties alone do not establish clinical superiority.</p>","PeriodicalId":257,"journal":{"name":"Bioorganic Chemistry","volume":"185 ","pages":"110737"},"PeriodicalIF":5.1,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149376598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Competitive inhibition of human carbonyl reductase 1 by the ketal-masked panaxfuraynes A and B: A computational-enzymatic study. 金掩膜panaxfuraynes A和B对人羰基还原酶1竞争性抑制的计算酶学研究。
IF 5.1 2区 医学
Bioorganic Chemistry Pub Date : 2026-11-04 DOI: 10.1016/j.bioorg.2026.110720
Sang-Seop Lee, Sang Myung Lee, Jong Seok Kim, Byung Soo Lee, Yung Choon Yoo
{"title":"Competitive inhibition of human carbonyl reductase 1 by the ketal-masked panaxfuraynes A and B: A computational-enzymatic study.","authors":"Sang-Seop Lee, Sang Myung Lee, Jong Seok Kim, Byung Soo Lee, Yung Choon Yoo","doi":"10.1016/j.bioorg.2026.110720","DOIUrl":"https://doi.org/10.1016/j.bioorg.2026.110720","url":null,"abstract":"<p><p>Carbonyl reductase 1 (CBR1) is an NADPH-dependent enzyme that reduces doxorubicin to doxorubicinol and is therefore of pharmacological interest as a modulator of anthracycline metabolism. Panaxfuraynes A and B are tetrahydrofuran-type polyacetylene sophorosides from Panax ginseng C.A. Meyer whose biological activities have remained uncharacterised since their isolation in 2009. Here we identify both compounds as inhibitors of human CBR1 and examine the structural basis of their activity. The parent glycosides possess defined chemical structures with little bioactivity annotation, so ligand-based target prediction was uninformative; metabolic analysis instead suggested sequential deglycosylation and ring opening to expose a conjugated ynone, directing attention to carbonyl reduction and CBR1. Catalytic-site binding was evaluated by molecular docking and three independent 100-ns molecular-dynamics simulations, and potency and inhibition mode were then determined by enzyme kinetics against recombinant human CBR1 and the homologous CBR3. Velocity data measured across five substrate and four inhibitor concentrations were fitted globally and compared across four inhibition models by Akaike information criterion. At CBR1 the competitive model was preferred, giving inhibition constants of 1.06 ± 0.14 and 1.68 ± 0.24 μM for panaxfuraynes A and B against a Michaelis constant of 54.6 ± 6.6 μM. At CBR3 the mixed model was preferred and the competitive model was rejected, giving inhibition constants of 9.59 ± 2.61 and 18.37 ± 7.66 μM with α values of 9.2 ± 6.1 and 3.6 ± 2.5, so the preference for CBR1 is approximately ninefold. The apparent IC50 against CBR1 rose linearly from 3.2 to 14.5 μM as the substrate concentration rose from 50 to 800 μM, the relationship expected of competitive inhibition. Curcumin, assayed as a positive control (Table S7 and Fig. S9) under identical conditions, inhibited CBR1 with an apparent IC50 of 1.13 ± 0.02 μM. Detergent, thiol, extended-preincubation and enzyme-free controls supported reversible, non-aggregating inhibition. These findings establish the first reported biological activity of panaxfuraynes and identify a ketal at the carbon that carbonyl reductase would otherwise reduce as a structural feature associated with competitive inhibition of CBR1, providing chemical probes for carbonyl-reductase recognition.</p>","PeriodicalId":257,"journal":{"name":"Bioorganic Chemistry","volume":"185 ","pages":"110720"},"PeriodicalIF":5.1,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149384906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification and characterization of a dual antagonist for mu and kappa opioid receptors from Menispermum dauricum DC. 月桂草阿片受体mu和kappa双拮抗剂的鉴定和鉴定。
IF 5.1 2区 医学
Bioorganic Chemistry Pub Date : 2026-11-03 DOI: 10.1016/j.bioorg.2026.110721
Jiaqi Huo, Fangfang Xu, Jixia Wang, Tao Hou, Yanfang Liu, Xiaomin Xie, Cheng Wang, Yang Han, Ling Ding
{"title":"Identification and characterization of a dual antagonist for mu and kappa opioid receptors from Menispermum dauricum DC.","authors":"Jiaqi Huo, Fangfang Xu, Jixia Wang, Tao Hou, Yanfang Liu, Xiaomin Xie, Cheng Wang, Yang Han, Ling Ding","doi":"10.1016/j.bioorg.2026.110721","DOIUrl":"https://doi.org/10.1016/j.bioorg.2026.110721","url":null,"abstract":"<p><p>Opioid receptors, particularly mu-opioid receptors (MOR), represent primary targets for analgesia. Opioid analgesics cause peripheral adverse effects that current symptomatic therapies fail to address, highlighting the need for novel acting MOR antagonists. The aim of this study was to identify and characterize MOR antagonists from alkaloids of Menispermum dauricum DC. We established a high-throughput screening platform targeting all four opioid receptor subtypes using FLIPR assays. A library of 20 alkaloids derived from Menispermum dauricum DC was subsequently screened against MOR, leading to the identification of an alkaloid not previously characterized as a functional MOR antagonist. Its antagonistic activity was validated using complementary label-free phenotypic dynamic mass redistribution (DMR) assays and cAMP-based functional assays. MOR antagonism was consistently reproduced across FLIPR, DMR, and cAMP assays, with pIC₅₀ values of 5.23 ± 0.04, 5.62 ± 0.05, and 5.52 ± 0.17, respectively. Selectivity profiling showed that the compound also antagonized KOR (pIC<sub>50</sub> = 5.47 ± 0.04 and 4.91 ± 0.05 in FLIPR and cAMP assays, respectively), with no detectable activity at delta-opioid receptor (DOR) or nociceptin/orphanin FQ receptor (NOPR). Moreover, it displayed negligible cross-reactivity against five unrelated GPCRs. Molecular docking and molecular dynamics simulations were further performed to delineate its binding mode with MOR and to suggest key residues governing ligand-receptor interactions. Collectively, these findings establish compound 1 as a promising natural product-derived scaffold for further optimization.</p>","PeriodicalId":257,"journal":{"name":"Bioorganic Chemistry","volume":"185 ","pages":"110721"},"PeriodicalIF":5.1,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149376599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antileishmanial and antimalarial activities of synthetic marine endoperoxides. 合成海洋内过氧化物的抗利什曼原虫和抗疟疾活性。
IF 5.1 2区 医学
Bioorganic Chemistry Pub Date : 2026-11-02 DOI: 10.1016/j.bioorg.2026.110716
Lukas Montejo, Estelle Messe, Mélanie Héry, Mansour Dolé Kerim, Nicolas Jamey, Laurent Evanno, Isabelle Florent, Sébastien Pomel, Laurent Ferrié
{"title":"Antileishmanial and antimalarial activities of synthetic marine endoperoxides.","authors":"Lukas Montejo, Estelle Messe, Mélanie Héry, Mansour Dolé Kerim, Nicolas Jamey, Laurent Evanno, Isabelle Florent, Sébastien Pomel, Laurent Ferrié","doi":"10.1016/j.bioorg.2026.110716","DOIUrl":"https://doi.org/10.1016/j.bioorg.2026.110716","url":null,"abstract":"<p><p>Synthetic samples and analogs of marine endoperoxides derived from mycaperoxides and plakortides were screened for their antileishmanial and antimalarial activities. It was found that these compounds exhibited significant activity against both parasites in the micromolar range. However, mycaperoxide analogs also exhibited high cytotoxicity against both cancer and healthy mammalian cell lines in the micromolar range. By contrast, ethyl plakortide Z showed minimal to no cytotoxic activity, leading to interesting potential against Plasmodium falciparum (IC<sub>50</sub> = 2.90 ± 1.13 μM, SI > 62) and Leishmania major (IC<sub>50</sub> = 16.87 ± 2.04 μM, SI > 5.9). The specific cytotoxicities of mycaperoxides might be attributed to the carboxylic acid functional group, which is absent in ethyl plakortide Z.</p>","PeriodicalId":257,"journal":{"name":"Bioorganic Chemistry","volume":"185 ","pages":"110716"},"PeriodicalIF":5.1,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149400509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Facile synthesis, antibacterial activity, in silico molecular docking analysis, and pharmacokinetic properties of N-methyl anthranilate-based compounds. n -甲酰苯甲酸酯类化合物的易合成、抗菌活性、硅分子对接分析和药代动力学性质。
IF 5.1 2区 医学
Bioorganic Chemistry Pub Date : 2026-10-30 DOI: 10.1016/j.bioorg.2026.110693
Fatma Salaheldin Mohamed, Mamdouh A Abu-Zaied, Daniel Jan Strub, Balcerzak Lucyna, Ahmed I Hashem, Mahmoud F Ismail, G A M Nawwar
{"title":"Facile synthesis, antibacterial activity, in silico molecular docking analysis, and pharmacokinetic properties of N-methyl anthranilate-based compounds.","authors":"Fatma Salaheldin Mohamed, Mamdouh A Abu-Zaied, Daniel Jan Strub, Balcerzak Lucyna, Ahmed I Hashem, Mahmoud F Ismail, G A M Nawwar","doi":"10.1016/j.bioorg.2026.110693","DOIUrl":"https://doi.org/10.1016/j.bioorg.2026.110693","url":null,"abstract":"&lt;p&gt;&lt;p&gt;In this work, a diverse series of 2-(methylamino)benzohydrazide-derived heterocyclic compounds were synthesized from the natural methyl N-methyl anthranilate (methyl 2-(methylamino)benzoate (DMA)), isolated from petitgrain mandarin (PGM) essential oil, which served as a key starting material throughout all synthetic routes. The target compounds were obtained via a simple and efficient synthetic protocol, providing yields in the range of 58-98%. The synthesized series included Schiff base derivatives 3a-g, 4,5-dihydro-1,3,4-oxadiazole derivatives, 4a-f, spiro[indoline-3,2'-[1,3,4]oxadiazol]-2-one derivative 9, oxadiazole derivative 6, 13, oxadiazole thioglycoside derivatives 15a,b; 16a,b, and triazole derivatives 18a,b. Structural elucidation of the synthesized derivatives was confirmed through elemental analyses and spectroscopic techniques (IR, &lt;sup&gt;1&lt;/sup&gt;H NMR,&lt;sup&gt;13&lt;/sup&gt;C NMR, and mass spectrometry). The in vitro antimicrobial activity of the synthesized compounds was evaluated against a panel of Gram-positive, Gram-negative bacteria and pathogenic fungi in comparison with standard drugs. Schiff base derivative 3c displayed outstanding broad-spectrum antimicrobial efficacy. The triazole derivatives 18a and 18b demonstrated notable antimicrobial activity against both bacterial and fungal strains. Notably, compound 18b exhibited notable in vitro antibacterial and antifungal activities against selected microorganisms, with MIC values reaching 1.57 μg/mL. Structure-activity relationship (SAR) analysis revealed that antimicrobial potency was strongly influenced by both the nature of substituents and the type of heterocyclic ring system. The incorporation of imine groups (as found in Schiff base derivatives) and hydrogen-bond-forming functionalities was found to enhance antibacterial activity, whereas cyclization to the corresponding dihydro-oxadiazole and oxadiazole rings resulted in a reduction of the antibacterial potency. In contrast, cyclization into a triazole ring markedly improved antifungal properties. Molecular docking studies were performed using AutoDock 4.0 against dihydrofolate reductase, revealing predicted binding affinities in the range of -8.40 to -9.65 kcal/mol. Drug-likeness properties for the most active compounds were assessed using SwissADME and pkCSM. The tested compounds complied with Lipinski's Rule of Five without any violations. ADMET predictions suggested generally favorable intestinal absorption and drug-like characteristics, while identifying several potential liabilities, including predicted CYP inhibition, Ames positivity for 4a, hERG II inhibition for 18a and 18b, and hepatotoxicity for 18b. These computational predictions require experimental validation. MD simulations were performed to further explore the dynamic behavior of the selected compounds within the investigated binding site. Collectively, these findings highlight compound 3c as a promising antibacterial lead and suggest compounds 18a and 18b as ","PeriodicalId":257,"journal":{"name":"Bioorganic Chemistry","volume":"185 ","pages":"110693"},"PeriodicalIF":5.1,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149384909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Design, synthesis, and evaluation of anti-orthoflavivirus Anchimerically HINT1 Activatable (AHA) ProTides. 抗正黄病毒HINT1活化(AHA)蛋白的设计、合成和评价。
IF 5.1 2区 医学
Bioorganic Chemistry Pub Date : 2026-10-27 DOI: 10.1016/j.bioorg.2026.110700
Jigar Sethiya, Pratip Kumar Dutta, Bryan Magana, Romário Matos, Kostana Ligori, Gustavo Peixoto Duarte da Silva, Rafaela Barbosa da Silva Pinto, Raphael Rodrigues Brambila, Johan Neyts, Suzanne Kaptein, Luciana Jesus da Costa, Carston Wagner
{"title":"Design, synthesis, and evaluation of anti-orthoflavivirus Anchimerically HINT1 Activatable (AHA) ProTides.","authors":"Jigar Sethiya, Pratip Kumar Dutta, Bryan Magana, Romário Matos, Kostana Ligori, Gustavo Peixoto Duarte da Silva, Rafaela Barbosa da Silva Pinto, Raphael Rodrigues Brambila, Johan Neyts, Suzanne Kaptein, Luciana Jesus da Costa, Carston Wagner","doi":"10.1016/j.bioorg.2026.110700","DOIUrl":"https://doi.org/10.1016/j.bioorg.2026.110700","url":null,"abstract":"<p><p>Orthoflaviviruses continue to pose a growing global health burden as climate change, urbanization, and diagnostic challenges drive increasing cases of dengue, Zika, and yellow fever virus infections. Despite this burden, no small-molecule antiviral has been approved for orthoflavivirus infections. Although 2'C-modified nucleoside analogues possess broad-spectrum antiviral potential, their utility is often limited by poor cellular uptake and inefficient intracellular activation. Existing phosphoramidate ProTides depend on esterase-mediated unmasking, which can lead to poor tissue tropism. Here, we expanded our recently reported Anchimeric HINT1-Activatable (AHA) ProTide platform, a non-ester phosphoramidate prodrug strategy designed to bypass carboxylesterase-dependent activation. A series of analogues incorporating diverse purine and pyrimidine nucleobases, 2'C-sugar modifications, and thermolytic thioether masking groups were synthesized and evaluated. Anchimeric activation rates were independent of nucleobase identity but were strongly affected by masking-group chain length, with half-lives of approximately 5 h and 15 h for AHA-Et and AHA-Bt analogues, respectively. Structure-activity relationship studies revealed a pronounced nucleobase dependence, with antiviral activity observed only among purine analogues. In contrast, pyrimidine analogues bearing 2'C-α-fluoro modifications were inactive in Vero cells. Combined with HINT1 kinetic analyses demonstrating poor processing of selected inactive AHA ProTides, these findings indicate that CES1 deficiency alone does not account for the lack of antiviral activity and highlight HINT1 substrate recognition as a critical determinant of successful prodrug activation. Among the compounds evaluated, AHA ProTide 5f showed the strongest activity against DENV-2 (EC<sub>50</sub> = 22 ± 1 μM) and ZIKV (EC<sub>50</sub> = 3 ± 2 μM) without detectable cytotoxicity up to 100 μM. These findings provide design principles for next-generation HINT1-activated, non-ester phosphoramidate ProTides.</p>","PeriodicalId":257,"journal":{"name":"Bioorganic Chemistry","volume":"185 ","pages":"110700"},"PeriodicalIF":5.1,"publicationDate":"2026-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149384907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A tumor-targeting strategy based on covalent aptamer-carborane conjugates. 基于共价适体-碳硼烷缀合物的肿瘤靶向策略。
IF 5.1 2区 医学
Bioorganic Chemistry Pub Date : 2026-10-15 Epub Date: 2026-09-18 DOI: 10.1016/j.bioorg.2026.110553
Xiaolu Zhou, Shaokang Jia, Shengjie Xie, Shanshan Qin, Xiang Zhou
{"title":"A tumor-targeting strategy based on covalent aptamer-carborane conjugates.","authors":"Xiaolu Zhou, Shaokang Jia, Shengjie Xie, Shanshan Qin, Xiang Zhou","doi":"10.1016/j.bioorg.2026.110553","DOIUrl":"10.1016/j.bioorg.2026.110553","url":null,"abstract":"<p><p>The development of tumor-targeting agents is of great significance for cancer therapy. Despite the promising potential of Boron Neutron Capture Therapy (BNCT), efficient and selective accumulation of boron-10 agents in cancer cells remains challenging. Conjugation of carborane with tumor-targeting ligands provides an alternative strategy for selective accumulation in the vicinity of cancer cells. In this study, we designed and synthesized aptamer-carborane derivatives, named AS1411-CB conjugates, via covalent linkage between a dodecahydro-arachno-bis(acetonitrile)decaborane and the DNA aptamer AS1411. AS1411 specifically binds to nucleolin, which is frequently overexpressed on the surface of cancer cells, thus enables selective targeting. Circular dichroism analysis indicated that AS1411-CB conjugates retained the characteristic G-quadruplex conformation of AS1411. Incorporation of a 5-Carboxyfluorescein (FAM) fluorescent label on AS1411 allowed flow cytometry analysis, which demonstrated significantly higher association of AS1411-CB conjugates with MCF-7 breast cancer cells compared with MCF-10 A normal mammary epithelial cells. Confocal microscopy further confirmed preferential localization of AS1411-CB conjugates on the surface of MCF-7 cells, consistent with nucleolin-mediated targeting. These results demonstrated that AS1411-CB conjugates preserved the targeting capability of AS1411 and highlighted its potential as a boron delivery platform for tumor-targeting applications.</p>","PeriodicalId":257,"journal":{"name":"Bioorganic Chemistry","volume":"182 ","pages":"110553"},"PeriodicalIF":5.1,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149014989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书